CD274 and cancer: In this study, to determine the relationship of biomarkers for patient stratification in the immunotherapy of patients with advanced solid tumors, we compared PD-L1 IHC results with TMB values and the percentage of unstable microsatellite loci using a commercially available comprehensive cancer panel assay (CCPA) with >500 genes.